Format

Send to

Choose Destination
Pituitary. 2016 Apr;19(2):194-201. doi: 10.1007/s11102-015-0698-6.

A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.

Author information

1
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
2
Department of Neurosurgery, Beijing Electric Power Hospital, Capital Medical University, Beijing, China.
3
Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
4
Department of Microbiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. yswang@ccmu.edu.cn.
5
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. dabiaozhou@163.com.

Abstract

OBJECTIVE:

Pituitary adenomas are benign neoplasms that display invasive behavior-a characteristic traditionally associated with malignancy-through an ill-defined mechanism. The role of angiogenesis-related molecules in this pathological condition remains perplexing. Our purpose is to assess the impact of endocan (endothelial cell specific molecule-1, ESM-1), CD34 and CD105 on pituitary adenoma invasion.

METHODS:

In this study, immunohistochemical analyses for endocan, CD34 and CD105 were performed on paraffin-embedded samples of 66 pituitary adenomas, five normal pituitaries, and five primary hepatic carcinomas. Knosp tumor grades based on magnetic resonance imaging coronal scanning were used to assess the invasiveness of each sample. The associations between endocan expression, CD34/CD105-positive microvessel densities (MVDs), and Knosp tumor invasion grades were evaluated.

RESULTS:

These results showed that endocan protein expression in tumor cells (TCs) was higher than that in endothelial cells (ECs) and strongly correlated with Knosp grades (P < 0.001, Spearman's r = 0.616). Moreover, while endocan-positive TCs localized around the blood vessels in adenomas with higher Knosp grades, no significant association was found between CD34/CD105-MVDs and Knosp grades (CD34: P = 0.256, r = 0.142; CD105: P = 0.183, r = 0.166). Normal pituitary seemed to exhibit lower endocan expression and contained more CD34/CD105-MVDs than pituitary adenomas.

CONCLUSION:

Endocan expresses in both TCs and ECs of pituitary adenoma. Endocan overexpression in TCs more accurately reflects invasiveness compared to that of CD34/CD105-MVDs and that angiogenesis may not be the primary driver of endocan-medicated pituitary adenoma invasion.

KEYWORDS:

Endocan; Immunohistochemistry; Pituitary adenoma; Tumor invasion

PMID:
26809958
PMCID:
PMC4799238
DOI:
10.1007/s11102-015-0698-6
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center